<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02992392</url>
  </required_header>
  <id_info>
    <org_study_id>2016-007</org_study_id>
    <nct_id>NCT02992392</nct_id>
  </id_info>
  <brief_title>Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome</brief_title>
  <official_title>Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been
      developed in which phospholipid liposomes are delivered to the tear film via the surface of
      the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte
      application on the lipid and stability of the tear film in dry eye patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>scale of Schirmer I test</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of corneal fluorescein staining</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of noninvasive tear breakup time</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of tear meniscus height</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>lipid layer grade</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>questionnaire of ocular surface disease index</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>subjective comfort</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
    <description>Subjective comfort was established at each time-point by asking subjects, firstly, to relate their comfort to baseline in each eye (more comfortable/no different/less comfortable) . secondly, to express a preference for their more comfortable eye (right eye/left eye/no difference)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Liposic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liposic was applied to one eye of patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tears Naturale Forte</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tears Naturale Forte was applied to one eye of patients in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposic</intervention_name>
    <description>one eye of the participant recieved Lipoic</description>
    <arm_group_label>Liposic</arm_group_label>
    <other_name>Carbomer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tears Naturale Forte</intervention_name>
    <description>the other eye of the participant recieved Tears Naturale Forte</description>
    <arm_group_label>Tears Naturale Forte</arm_group_label>
    <other_name>DEXTRAN/HYPROMELLOSE/GLYCERIN</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age of 20 years(range from 20 year to 25 years)

          -  The value of OSDI is over 12

          -  NBUT is less 5 seconds

          -  Schirmer 1 test is less 10mm

          -  The basical lipid layer grade is 1-2

        Exclusion Criteria:

          -  Any corneal,conjunctival, or eyelid abnormalities; conjunctivitis; current ocular
             infection; photophobia that may cause reflex tearing or difficulty in evaluating the
             patient's lipid layer;

          -  Known allergic sensitivity to any of the ingredients in Liposic or Tears Naturale
             Forte
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xingwu Zhong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chi Zhang, MD,PhD</last_name>
    <email>mike0946@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen University</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xingwu Zhong, MD,PhD</last_name>
      <phone>+86(898)68628481</phone>
      <email>zhongxwu@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2016</study_first_submitted>
  <study_first_submitted_qc>December 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2016</study_first_posted>
  <last_update_submitted>December 14, 2016</last_update_submitted>
  <last_update_submitted_qc>December 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xingwu Zhong, MD PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Tear film</keyword>
  <keyword>Lipid layer</keyword>
  <keyword>Liposic</keyword>
  <keyword>Tears Naturale Forte</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dextrans</mesh_term>
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

